|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-7-31
|
|
pubmed:abstractText |
Leukotriene receptor antagonists have been shown to protect against bronchoconstriction induced by antigens, exercise, and cold air. There are relatively few clinical studies reported in patients with asthma. The present study is the first clinical evaluation of pranlukast (SB 205312, ONO-1078) outside Japan in patients with asthma.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-1337128,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-1416420,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-1672176,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-1952571,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-2174121,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-2554766,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-41240,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-7514876,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-8087328,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-8239223,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-8409112,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9227718-8497683
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0040-6376
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
523-7
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9227718-Administration, Oral,
pubmed-meshheading:9227718-Adult,
pubmed-meshheading:9227718-Aged,
pubmed-meshheading:9227718-Analysis of Variance,
pubmed-meshheading:9227718-Anti-Asthmatic Agents,
pubmed-meshheading:9227718-Asthma,
pubmed-meshheading:9227718-Chromones,
pubmed-meshheading:9227718-Double-Blind Method,
pubmed-meshheading:9227718-Female,
pubmed-meshheading:9227718-Forced Expiratory Volume,
pubmed-meshheading:9227718-Humans,
pubmed-meshheading:9227718-Leukotriene Antagonists,
pubmed-meshheading:9227718-Lung,
pubmed-meshheading:9227718-Male,
pubmed-meshheading:9227718-Middle Aged,
pubmed-meshheading:9227718-Peak Expiratory Flow Rate,
pubmed-meshheading:9227718-Time Factors
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.
|
|
pubmed:affiliation |
London Chest Hospital, Department of Respiratory Medicine, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
